SLU-PP-332 — 5 mg

SLU-PP-332 is a chemical agonist of estrogen-related receptors ERRα, ERRβ, and ERRγ. These nuclear receptors regulate transcriptional programs associated with cellular energy handling and mitochondrial metabolism. Despite its frequent placement alongside research peptides, SLU-PP-332 is not an amino-acid peptide. The term estrogen-related describes the receptor family and should not be confused with calling the compound an estrogen replacement.

An originating research study reported activation of an acute aerobic-exercise-associated gene program, increased oxidative muscle characteristics, and improved exercise capacity in mice. A subsequent metabolic-syndrome study described increased energy expenditure and fatty-acid oxidation, together with reduced fat accumulation and improved metabolic measures in mouse models. These findings underpin the exercise-mimetic and fat-metabolism language attached to the compound. They describe selected biological features of exercise rather than replication of every benefit of physical activity. The primary papers reviewed are preclinical investigations, not demonstrations of human athletic enhancement or weight-management outcomes. Their principal value is identifying ERR signaling as an experimentally accessible regulator of metabolic adaptation.